Based on the Option Care Health Inc stock forecast from 5 analysts, the average analyst target price for Option Care Health Inc is USD 35.20 over the next 12 months. Option Care Health Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Option Care Health Inc is Slightly Bullish , which is based on 8 positive signals and 4 negative signals. At the last closing, Option Care Health Inc’s stock price was USD 22.18. Option Care Health Inc’s stock price has changed by -5.62% over the past week, -25.02% over the past month and -24.79% over the last year.
No recent analyst target price found for Option Care Health Inc
No recent average analyst rating found for Option Care Health Inc
Company Overview Option Care Health Inc
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. Read Less
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and c...Read More
Frequently Asked Questions About Option Care Health Inc (OPCH) Stock
Based on ratings from 5 analysts Option Care Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 9 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on OPCH's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for OPCH is USD 35.20 over the next 12 months. The maximum analyst target price is USD 41 while the minimum anlayst target price is USD 27.
OPCH stock's Price/Earning ratio is 20.26.
Our analysis grades OPCH stock's Price / Earning ratio at D+. This means that OPCH stock's Price/Earning ratio is above 31.00000000000001% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this OPCH may be fairly valued for its sector
The last closing price of OPCH's stock was USD 22.18.
The most recent market capitalization for OPCH is USD 4.10B.
Based on targets from 5 analysts, the average taret price for OPCH is projected at USD 35.20 over the next 12 months.
This means that OPCH's stock price may go up by +58.70% over the next 12 months.
We can't find any ETFs which contains Option Care Health Inc's stock.
As per our most recent records Option Care Health Inc has 7,500 Employees.
Option Care Health Inc's registered address is 3000 Lakeside Drive, Bannockburn, IL, United States, 60015.
You can get more information about it from Option Care Health Inc's website at https://www.optioncarehealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Option Care Health Inc (OPCH) Stock
Based on ratings from 5 analysts Option Care Health Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 9 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on OPCH's stock to indicate if its a good dividend stock.
Based on targets from 5 analysts, the average taret price for OPCH is USD 35.20 over the next 12 months. The maximum analyst target price is USD 41 while the minimum anlayst target price is USD 27.
OPCH stock's Price/Earning ratio is 20.26.
Our analysis grades OPCH stock's Price / Earning ratio at D+. This means that OPCH stock's Price/Earning ratio is above 31.00000000000001% of the stocks in the Medical Care Facilities sector in the NSD exchange.
Based on this OPCH may be fairly valued for its sector
The last closing price of OPCH's stock was USD 22.18.
The most recent market capitalization for OPCH is USD 4.10B.
Based on targets from 5 analysts, the average taret price for OPCH is projected at USD 35.20 over the next 12 months.
This means that OPCH's stock price may go up by +58.70% over the next 12 months.
We can't find any ETFs which contains Option Care Health Inc's stock.
As per our most recent records Option Care Health Inc has 7,500 Employees.
Option Care Health Inc's registered address is 3000 Lakeside Drive, Bannockburn, IL, United States, 60015.
You can get more information about it from Option Care Health Inc's website at https://www.optioncarehealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for OPCH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
